{"id":"https://openalex.org/W1970156124","doi":"https://doi.org/10.2337/diacare.28.12.2985","title":"A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia","display_name":"A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia","alternate_titles":[],"publication_year":2005,"publication_date":"2005-12-01","ids":{"openalex":"https://openalex.org/W1970156124","doi":"https://doi.org/10.2337/diacare.28.12.2985","mag":"1970156124"},"language":"en","primary_location":{"id":"doi:10.2337/diacare.28.12.2985","doi":"https://doi.org/10.2337/diacare.28.12.2985","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diacare.28.12.2985","pdf_url":"https://diabetesjournals.org/care/article-pdf/28/12/2985/563064/zdc01205002985.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1970156124"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://diabetesjournals.org/care/article-pdf/28/12/2985/563064/zdc01205002985.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011389314","display_name":"Ronald B Goldberg","orcid":"https://orcid.org/0000-0003-0924-1110","observed_orcids":["https://orcid.org/0000-0003-0924-1110"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ronald B. Goldberg","raw_affiliation_strings":["Division of Endocrinology, Metabolism and Diabetes, University of Miami School of Medicine, Miami, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Metabolism and Diabetes, University of Miami School of Medicine, Miami, Florida","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013350892","display_name":"David M. Kendall","orcid":"https://orcid.org/0000-0003-1910-2587","observed_orcids":["https://orcid.org/0000-0003-1910-2587"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David M. Kendall","raw_affiliation_strings":["International Diabetes Center, Park Nicollet Institute, Minneapolis, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Diabetes Center, Park Nicollet Institute, Minneapolis, Minnesota","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057449551","display_name":"Mark A. Deeg","orcid":"https://orcid.org/0000-0001-6920-9396","observed_orcids":["https://orcid.org/0000-0001-6920-9396"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark A. Deeg","raw_affiliation_strings":["Division of Endocrinology and Metabolism, Department of Veterans Affairs and the Indiana University School of Medicine, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology and Metabolism, Department of Veterans Affairs and the Indiana University School of Medicine, Indianapolis, Indiana","institution_ids":["https://openalex.org/I4388446366","https://openalex.org/I4394709130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040182038","display_name":"John B. Buse","orcid":"https://orcid.org/0000-0002-9723-3876","observed_orcids":["https://orcid.org/0000-0002-9723-3876"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John B. Buse","raw_affiliation_strings":["Divisions of Endocrinology and of General Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisions of Endocrinology and of General Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012043091","display_name":"Anthony J. Zagar","orcid":"https://orcid.org/0000-0002-8353-6665","observed_orcids":["https://orcid.org/0000-0002-8353-6665"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anthony J. Zagar","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018937404","display_name":"Jane A. Pinaire","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jane A. Pinaire","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016547950","display_name":"Meng Hee Tan","orcid":"https://orcid.org/0000-0001-6674-2611","observed_orcids":["https://orcid.org/0000-0001-6674-2611"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Meng H. Tan","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103944459","display_name":"Mehmood A. Khan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mehmood A. Khan","raw_affiliation_strings":["Takeda Pharmaceuticals North America, Lincolnshire, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals North America, Lincolnshire, Illinois","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103745313","display_name":"Alfonso T. Perez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alfonso T. Perez","raw_affiliation_strings":["Takeda Global Research and Development Center, Lincolnshire, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Global Research and Development Center, Lincolnshire, Illinois","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110236818","display_name":"Scott J. Jacober","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Scott J. Jacober","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":null,"display_name":"for the GLAI Study Investigators","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"for the GLAI Study Investigators","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5110236818"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":null,"apc_paid":null,"fwci":1.3891,"has_fulltext":true,"cited_by_count":59,"citation_normalized_percentile":{"value":0.8037924,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"28","issue":"12","first_page":"2985","last_page":"2986"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8428000211715698,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8428000211715698,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.09529999643564224,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.04349999874830246,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9959999918937683},{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"rosiglitazone","score":1.0},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9369999766349792},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9959999918937683},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.902999997138977},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.8220000267028809},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.9100000262260437},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.7129999995231628},{"id":"https://openalex.org/keywords/statin-therapy","display_name":"statin therapy","score":0.7110000252723694}],"concepts":[{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.9425418972969055},{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.9367029666900635},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9332468509674072},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.8845854997634888},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.7328437566757202},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7264670729637146},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6896668076515198},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6583164930343628},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.45739421248435974}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/diacare.28.12.2985","doi":"https://doi.org/10.2337/diacare.28.12.2985","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diacare.28.12.2985","pdf_url":"https://diabetesjournals.org/care/article-pdf/28/12/2985/563064/zdc01205002985.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.2337/diacare.28.12.2985","doi":"https://doi.org/10.2337/diacare.28.12.2985","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diacare.28.12.2985","pdf_url":"https://diabetesjournals.org/care/article-pdf/28/12/2985/563064/zdc01205002985.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1970156124.pdf","grobid_xml":"https://content.openalex.org/works/W1970156124.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W1975298329","https://openalex.org/W1982990554","https://openalex.org/W1986229866","https://openalex.org/W2049571309","https://openalex.org/W2102675827","https://openalex.org/W2124186024","https://openalex.org/W2131215476"],"related_works":["https://openalex.org/W2102675827","https://openalex.org/W7218130992","https://openalex.org/W2109934064","https://openalex.org/W2120086542","https://openalex.org/W2107298817","https://openalex.org/W37315064","https://openalex.org/W2183844286","https://openalex.org/W2020625666","https://openalex.org/W2124880104","https://openalex.org/W2003731317"],"abstract_inverted_index":{"In":[0,87],"his":[1],"commentary,":[2],"Bell":[3,23],"(1)":[4],"presents":[5],"specific":[6],"criticisms":[7],"of":[8,15,35,40,52,80,83],"the":[9,13,32,38,46,50,72,81,84,90,98,110],"head-to-head":[10],"trial":[11],"comparing":[12],"effects":[14,77],"rosiglitazone":[16],"with":[17],"pioglitazone":[18],"on":[19,42,60,78],"lipids":[20],"and":[21,45,63],"lipoproteins.":[22],"raises":[24],"a":[25],"concern":[26],"over":[27],"study":[28],"recruitment":[29],"(in":[30],"particular":[31],"high":[33],"rate":[34],"screen":[36],"failures),":[37],"exclusion":[39],"patients":[41,59],"statin":[43],"therapy,":[44],"limited":[47],"data":[48],"supporting":[49],"role":[51],"hypertriglyceridemia":[53],"in":[54],"cardiovascular":[55],"risk.":[56],"By":[57],"excluding":[58],"other":[61],"glucose-":[62],"lipid-lowering":[64],"medication,":[65],"we":[66],"were":[67,107],"able":[68],"to":[69,97],"demonstrate":[70],"that":[71],"two":[73],"agents":[74],"have":[75],"different":[76],"each":[79],"components":[82],"lipid":[85],"profile.":[86],"doing":[88],"so,":[89],"differences":[91],"observed":[92],"could":[93],"only":[94],"be":[95],"attributed":[96],"active":[99,111],"thiazolidinedione":[100],"(TZD)":[101],"therapy.":[102],"Targets":[103],"for":[104],"LDL":[105],"cholesterol":[106],"lowered":[108],"during":[109],"\u2026":[112]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1970156124","counts_by_year":[{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
